|
|
|
BioSilta |
 |
| |
| BioSilta was founded in 2007 as a spin-out from the University of Oulu and has offices in Oulu, Finland, and Berlin, Germany. BioSilta develops, produces and markets the novel EnBaseŽ technology as a novel advanced tool for microbial cell cultivation, protein production, enzyme screening, plasmid preparation and food spoilage testing. The patented EnBase technology resembles the fed-batch process and provides a cultivation environment with glucose-control, pH maintenance and inhibition of growth-limiting metabolites without the need for traditional mechanical pumps. This powerful tool can be used with E. coli and other bacteria, yeast and development of a mammalian product is already underway. EnBase is provided in ready-to-use liquid or tablet products and can be used from small-scale cultures, such as microwell plates to shake flasks to small-scale bioreactors. Learn more about our products and applications at www.biosilta.com. |
|
|
|
|
|
| |
|
|
|
|
|
 |
Industry Events |
 |
BIO-EuropeŽ 2012
12-14 November 2012, Congress Center Hamburg, Hamburg, Germany
Building value through partnerships
BIO-EuropeŽ is the
preeminent partnering conference for the life sciences. BIO-Europe brings
together international decision makers from the biotechnology, pharmaceutical
and financial sectors, offering networking opportunities, workshop and panel
participation, a high profile exhibition, and private, prescheduled one-to-one
meetings.
More info >> |
|
 |
News and Press Releases |
 |
AstraZenenca teams up with GS1 UK for coding solutions
AstraZeneca is working with GS1 UK, a not-for-profit industry standards body, to use unique identification codes and sophisticated 2 Dimensional (2D) barcodes to keep automated records of dispensing information, expiry dates, batch validity and to monitor how pharmaceuticals move through the supply chain, helping reduce the risk of patients being given counterfeit or substandard medicines.
More info >> |
|
|
|
